LYNDSEY SHANNON: Open Payments
NPI 1013637735 · JEFFERSON CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,194 in 55 payments from 14 companies in 2025. Trend: 2023 $812 · 2024 $3,395 · 2025 $1,194
Food & beverage: $1,028Education: $166
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $463 |
| ABBVIE INC. | 10 | $141 |
| UCB, Inc. | 4 | $89 |
| Regeneron Healthcare Solutions, Inc. | 4 | $87 |
| Novartis Pharmaceuticals Corporation | 3 | $78 |
| Galderma Laboratories, L.P. | 3 | $61 |
| Amgen Inc. | 3 | $60 |
| Lilly USA, LLC | 3 | $52 |
| Incyte Corporation | 2 | $46 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $43 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Bimzelx, NEMLUVIO, TALTZ, OPZELURA, OTEZLA.
Industry payments across MO — which companies pay providers there.
